http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31663523

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study
endingPage 546
issn 0920-1211
issueIdentifier 3
pageRange 542-546
publicationName Epilepsy Research
startingPage 542
bibliographicCitation Cusmai R, Verrotti A, Moavero R, Curatolo P, Battaglia D, Matricardi S, Spalice A, Vigevano F, Pruna D, Parisi P, D'Aniello A, Di Gennaro G, Coppola G. Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. Epilepsy Res. 2014 Mar;108(3):542–6. doi: 10.1016/j.eplepsyres.2014.01.013. PMID: 24548548.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67646fce5bdabfbfea91f3d2ce8ef8dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9717477674c71bf6e4f9639f27aad9b3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a026aeefeb3d5e10edbbcdaa1c86deab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_489413b4f3c998aa5f04660968cb3865
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfc3f0591eb7bcff3950c1cdc7161ab4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8f7e55c929616184cafda79594134d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb81f6e7a2caebcf92ac18d651009069
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_412eb61750dbf3b08c9e4bda6b91fc42
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b12abaa09f733d2909e820f6cf5f1e51
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d305c033eda245cfaed9f52f872ffff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ae8e0f8ba765bbdba5710e0a641b398
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80a0962ebc5f8e37b59c97200e4c4d72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f77caf97c54f65ef44a0a300352b246
date 201403
identifier https://pubmed.ncbi.nlm.nih.gov/24548548
https://doi.org/10.1016/j.eplepsyres.2014.01.013
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders
discusses http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0021911
http://id.nlm.nih.gov/mesh/M0213280
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D054081Q000150
http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D014230Q000627
http://id.nlm.nih.gov/mesh/D004827Q000209
http://id.nlm.nih.gov/mesh/D004827Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D002675
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D005858
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D007558
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129228
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6522
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_afe23f1bf6ddb0f3302191ebe8f39d17
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11028
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8099
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6910
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617

Total number of triples: 60.